U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
IBI-306
Preferred Name English
TAFOLECIMAB
INN  
Official Name English
Tafolecimab [WHO-DD]
Common Name English
IBI306
Code English
IMMUNOGLOBULIN IGG2, ANTI-(HUMAN PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9) (HUMAN MONOCLONAL IBI306 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IBI306 .KAPPA.-CHAIN, DIMER
Common Name English
tafolecimab [INN]
Common Name English
Code System Code Type Description
NCI_THESAURUS
C171839
Created by admin on Wed Apr 02 04:24:25 GMT 2025 , Edited by admin on Wed Apr 02 04:24:25 GMT 2025
PRIMARY
CAS
2225109-03-3
Created by admin on Wed Apr 02 04:24:25 GMT 2025 , Edited by admin on Wed Apr 02 04:24:25 GMT 2025
PRIMARY
INN
11061
Created by admin on Wed Apr 02 04:24:25 GMT 2025 , Edited by admin on Wed Apr 02 04:24:25 GMT 2025
PRIMARY
SMS_ID
300000010816
Created by admin on Wed Apr 02 04:24:25 GMT 2025 , Edited by admin on Wed Apr 02 04:24:25 GMT 2025
PRIMARY
FDA UNII
KV2ZKH0NIM
Created by admin on Wed Apr 02 04:24:25 GMT 2025 , Edited by admin on Wed Apr 02 04:24:25 GMT 2025
PRIMARY
ACTIVE MOIETY
TAFOLECIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966